Stifel analyst Paul Matteis lowered the firm’s price target on Biogen (BIIB) to $144 from $175 and keeps a Hold rating on the shares. The ...

Stifel analysts maintained their Buy rating on Iovance Biotherapeutics (NASDAQ:IOVA), currently trading at $5.24, with a steady price target of $21.00. According to InvestingPro data, analyst targets ...

Stifel analysts increased their price target for Ecolab Inc . (NYSE:ECL) shares to $307.00, up from the previous $285.00, while reiterating a Buy rating on the stock. The company, currently valued at ...

Stifel Financial is a top pick for long-term growth with solid Q424 results, a 10% dividend hike & solid wealth management ...

Stifel Financial (SF) announced the launch of Stifel Discover, a new Stifel-branded content feed available through its Wealth Tracker app. The ...

GATX Corporation (NYSE: GATX) announced the cancellation of its presentation and webcast at the Stifel 2025 Transportation & ...

MoneyLion operates a “content-as-a-service platform” called mFeed, and Stifel Discover is expected to deliver personalized ...

Over the past five years, Stifel has hired 450 advisors, with a cumulative trailing 12-month production of more than $350 million, according to CFO Marischen. That has driven the wealth division’s ...

Tesla (NASDAQ:TSLA – Get Free Report) had its price objective cut by research analysts at Stifel Nicolaus from $492.00 to ...

(美国商业资讯)-- 全球领先的全数字化航空航天零部件制造商Sintavia, LLC今日宣布，已从Stifel North Atlantic AM-Forward Fund（以下简称“基金”）获得1000万美元的次级债务投资。这笔投资是最近推出的SBIC基金的首笔投资，其资金将用于为现有设备贷款再 ...

周三，Stifel分析师维持对Palo Alto ...

在其他近期新闻中，卡夫亨氏受到多位分析师评级调整。Jefferies分析师Rob Dickerson将卡夫亨氏目标价从34美元下调至30美元，同时维持"持有"评级。此次调整是基于观察到公司在美国市场，特别是第四季度出现显著的销量下滑和市场份额损失。